Transposagen Biopharmaceuticals, J&J deal

Transposagen granted Johnson & Johnson’s Janssen Pharmaceuticals unit exclusive, worldwide rights to allogeneic chimeric antigen receptor (CAR) T cell therapies developed by the partners using Transpo...